Should Intravenous Heparin Be Administered During Total Knee or Total Hip Arthroplasty?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAbedi, Armita A.
dc.contributor.authorTuncay, Ibrahim
dc.contributor.authorAdi, Mohamed M.
dc.contributor.authorTarabichi, Samih
dc.contributor.authorMemtsoudis, Stavros
dc.contributor.authorButtaro, Martin
dc.contributor.authorParvizi, Javad
dc.date.accessioned2025-10-16T15:12:04Z
dc.date.issued2025
dc.description.abstractWorld Expert Meeting in Arthroplasty, Istanbul, TURKEY, AUG 30-31, 2024
dc.identifier.doi10.1016/j.arth.2024.10.072
dc.identifier.otherWOS:001460344100017
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5219
dc.publisherCHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
dc.sourceJOURNAL OF ARTHROPLASTY
dc.subjecttotal joint replacement
dc.subjectperioperative care
dc.subjectthromboprophylaxis
dc.subjectintravenous heparin
dc.subjectpostoperative complications
dc.subjectperioperative anticoagulation
dc.titleShould Intravenous Heparin Be Administered During Total Knee or Total Hip Arthroplasty?
dc.typeArticle; Proceedings Paper

Dosyalar

Koleksiyonlar

WOS